International Journal of Infection

Published by: Kowsar

Toxoplasma gondii Seroprevalence Among Blood Donors in Zahedan, Southeastern Iran

Mohammad Jafari Modrek 1 , 2 , * , Mohammad Mousavi 2 and Ramin Saravani 3
Authors Information
1 Infectious Disease and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Department of Parasitology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Department of Clinical Biochemistry, Cellular and Molecular Research Center, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: July 30, 2014, 1 (2); e21111
  • Published Online: July 21, 2014
  • Article Type: Research Article
  • Received: June 11, 2014
  • Revised: June 15, 2014
  • Accepted: June 17, 2014
  • DOI: 10.17795/iji-21111

To Cite: Jafari Modrek M, Mousavi M, Saravani R. Toxoplasma gondii Seroprevalence Among Blood Donors in Zahedan, Southeastern Iran, Int J Infect. 2014 ; 1(2):e21111. doi: 10.17795/iji-21111.

Copyright © 2014, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: A systematic review and meta-analysis. Acta Trop. 2014; [DOI][PubMed]
  • 2. Gilbert R, Eskild P. Toxoplasmosis and pregnancy. 2013;
  • 3. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J. 2008; 14(1): 163-71[PubMed]
  • 4. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J Trop Med Public Health. 2009; 40(6): 1158-78[PubMed]
  • 5. Singh G, Sehgal R. Transfusion-transmitted parasitic infections. Asian J Transfus Sci. 2010; 4(2): 73-7[DOI][PubMed]
  • 6. Siegel SE, Lunde MN, Gelderman AH, Halterman RH, Brown JA, Levine AS, et al. Transmission of toxoplasmosis by leukocyte transfusion. Blood. 1971; 37(4): 388-94[PubMed]
  • 7. Sundar P, Mahadevan A, Jayshree RS, Subbakrishna DK, Shankar SK. Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka. Indian J Med Res. 2007; 126(1): 50-5[PubMed]
  • 8. Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol. 2003; 23(6): 618-24[DOI][PubMed]
  • 9. Alvarado-Esquivel C, Mercado-Suarez MF, Rodriguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, Nevarez-Piedra LJ, et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis. 2007; 7: 75[DOI][PubMed]
  • 10. Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin WC, Fan CK, et al. Seroepidemiology of Toxoplasma gondii Infection among healthy blood donors in Taiwan. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 11. Elhence P, Agarwal P, Prasad KN, Chaudhary RK. Seroprevalence of Toxoplasma gondii antibodies in North Indian blood donors: implications for transfusion transmissible toxoplasmosis. Transfus Apher Sci. 2010; 43(1): 37-40[DOI][PubMed]
  • 12. Liu Y, Zheng K, Chen M, Fu L, Du W, Shi Z. Study on detecting antibodies to Toxoplasma gondii in pooled serum of blood donors by Dot-IGSS. Southeast Asian J Trop Med Public Health. 2001; 32(3): 558-61[PubMed]
  • 13. Yazar S, Eser B, Yay M. Prevalence of anti-toxoplasma Gondii antibodies in Turkish blood donors. Ethiop Med J. 2006; 44(3): 257-61[PubMed]
  • 14. Yilmaz GR, Babur C, Kilic S, Taylan Ozkan A, Beyaz E, Karakoc AE. [Short communication: investigation of Toxoplasma gondii antibodies in blood donors by Sabin-Feldman Dye Test]. Mikrobiyol Bul. 2006; 40(4): 375-81[PubMed]
  • 15. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010; 50(10): 2080-99[DOI][PubMed]
  • 16. Coelho RA, Kobayashi M, Carvalho LB, Jr. Prevalence of IgG antibodies specific to Toxoplasma gondii among blood donors in Recife, Northeast Brazil. Rev Inst Med Trop Sao Paulo. 2003; 45(4): 229-31[PubMed]
  • 17. Makki SM, Abdel-Tawab AH. Anti-Toxoplasma gondii antibodies among volunteer blood donors in eastern Saudi Arabia. J Egypt Soc Parasitol. 2010; 40(2): 401-12[PubMed]
  • 18. Elsheikha HM, Azab MS, Abousamra NK, Rahbar MH, Elghannam DM, Raafat D. Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt. Parasitol Res. 2009; 104(6): 1471-6[DOI][PubMed]
  • 19. Pinlaor S, Ieamviteevanich K, Pinlaor P, Maleewong W, Pipitgool V. Seroprevalence of specific total immunoglobulin (Ig), IgG and IgM antibodies to Toxoplasma gondii in blood donors from Loei Province, Northeast Thailand. Southeast Asian J Trop Med Public Health. 2000; 31(1): 123-7[PubMed]
  • 20. Martin AM, Liu T, Lynn BC, Sinai AP. The Toxoplasma gondii parasitophorous vacuole membrane: transactions across the border. J Eukaryot Microbiol. 2007; 54(1): 25-8[DOI][PubMed]
  • 21. Gharehbaghian A, Abolghasemi H, Namini MT. Status of blood transfusion services in Iran. Asian J Transfus Sci. 2008; 2(1): 13-7[DOI][PubMed]
  • 22. Shaddel M, Mirzaii-Dizgah I, Hoshangi M. Anti-Toxoplasma gondii Antibody Levels in Blood Supply of Shiraz Blood Transfusion Institute, Iran. Iranian J Parasitol. 2014; 9(1): 120-4
  • 23. Sharif M, Daryani A, Barzegar G, Nasrolahei M. A seroepidemiological survey for toxoplasmosis among schoolchildren of Sari, Northern Iran. Trop Biomed. 2010; 27(2): 220-5[PubMed]
  • 24. Salahi-Moghaddam A, Hafizi A. A serological study on Toxoplasma gondii infection among people in south of Tehran, Iran. Korean J Parasitol. 2009; 47(1): 61-3[DOI][PubMed]
  • 25. Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R. [Toxoplasmosis in Iran. Results of a seroepidemiological study]. Bull Soc Pathol Exot. 1997; 90(1): 19-21[PubMed]
  • 26. Ghorbani M, Edrissian GH, Assad N. Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Trans R Soc Trop Med Hyg. 1978; 72(4): 369-71[PubMed]
  • 27. Sarkari B, Shafiei R, Zare M, Sohrabpour S, Kasraian L. Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran. J Infect Dev Ctries. 2014; 8(4): 543-7[DOI][PubMed]
  • 28. Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk-factors forToxoplasma gondiiinfection: prospective cross-sectional study among military personnel in the Czech Republic. Clinical Microbiology and Infection. 2007; 13(10): 1012-7[DOI]
  • 29. Zamorano CG, Contreras MC, Villalobos S, Sandoval L, Salinas P. [Seroepidemiological survey of human toxoplasmosis in Osorno, Region X, Chile, 1998]. Bol Chil Parasitol. 1999; 54(1-2): 33-6[PubMed]
  • 30. Movayedi B. The prevalence of infection with the protozoan blood transfusion of the blood donor base. J Med Sci Isfahan. 2000; 4(4): 217-31
  • 31. Hossain A. Investigate the reasons for deferral of donors attending the Blood Transfusion Center, Tehran. Hakim Res J. 2002; 5(2): 121
  • 32. Strabelli TM, Siciliano RF, Vidal Campos S, Bianchi Castelli J, Bacal F, Bocchi EA, et al. Toxoplasma gondii Myocarditis after Adult Heart Transplantation: Successful Prophylaxis with Pyrimethamine. J Trop Med. 2012; 2012: 853562[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments